Speaker
Description
The use of AVF cyclotrons for proton therapy in hospitals has been on the rise in recent years. However, further miniaturization is essential for wider adoption. Our company has previously succeeded in reducing the size of conventional AVF cyclotrons for proton therapy to approximately 60% of their original dimensions by implementing superconducting technology.
While synchrocyclotrons are relatively easy to miniaturize, AVF cyclotrons offer the advantage of continuous beams with high average beam current. This contributes to shorter treatment times, enabling less burdensome therapy for patients.
In this report, we present the results of a physical study on further miniaturization of superconducting AVF cyclotrons, focusing on aspects such as isochronism and beam extraction.
